Cat.#: ACPP-1349
| Despition | Estrogen Receptor alpha Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
| ACPP-1115 | Recombinant Human CD45 Protein (6×His Tag) (AC1115) | 50 µg | inquiry |
| ACPP-1148 | Recombinant Human NCAM1 Protein (Fc Tag) (AC1148) | 50 µg | inquiry |
| ACPP-1529 | Human KCTD4 Protein (AC1529) | 2 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
| ACPP-1756 | Human TSH Protein (AC1756) | 2 µg | inquiry |
| ACPP-1636 | Vasopressin (AC1636) | 5 mg | inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.